Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Jingyue Yan"'
Autor:
Yonger Xue, Yuebao Zhang, Yichen Zhong, Shi Du, Xucheng Hou, Wenqing Li, Haoyuan Li, Siyu Wang, Chang Wang, Jingyue Yan, Diana D. Kang, Binbin Deng, David W. McComb, Darrell J. Irvine, Ron Weiss, Yizhou Dong
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Adipose stem cells (ASCs) have attracted considerable attention as potential therapeutic agents due to their ability to promote tissue regeneration. However, their limited tissue repair capability has posed a challenge in achieving optimal t
Externí odkaz:
https://doaj.org/article/625c5a8ddd304299b6fd4d928fdfa3a5
Publikováno v:
Exploration, Vol 3, Iss 4, Pp n/a-n/a (2023)
Abstract Adoptive cell therapy (ACT) is a rapidly growing anti‐cancer strategy that has shown promise in treating various cancer types. The concept of ACT involves activating patients’ own immune cells ex vivo and then transferring them back to t
Externí odkaz:
https://doaj.org/article/09758395a3b5417ca0ffe36d1ec81b0c
Autor:
Shi Du, Wenqing Li, Yuebao Zhang, Yonger Xue, Xucheng Hou, Jingyue Yan, Jeffrey Cheng, Binbin Deng, David W. McComb, Jennifer Lin, Hong Zeng, Xiaolin Cheng, Darrell J. Irvine, Ron Weiss, Yizhou Dong
Publikováno v:
Advanced Science, Vol 10, Iss 11, Pp n/a-n/a (2023)
Abstract Male infertility caused by genetic mutations is an important type of infertility. Currently, there is no reliable method in the clinic to address this medical need. The emergence of mRNA therapy provides a possible strategy for restoring mut
Externí odkaz:
https://doaj.org/article/9d73ad80650f478b8530e1d5629c2893
Autor:
Wenqing Li, Xinfu Zhang, Chengxiang Zhang, Jingyue Yan, Xucheng Hou, Shi Du, Chunxi Zeng, Weiyu Zhao, Binbin Deng, David W. McComb, Yuebao Zhang, Diana D. Kang, Junan Li, William E. Carson, Yizhou Dong
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
Antibodies targeting OX40 or CD137, two T cell costimulatory receptors, have been shown to improve antitumor immunity. Here the authors design a phospholipid-derived nanoparticle to deliver OX40 or CD137 mRNA to T cells in vivo, improving efficacy of
Externí odkaz:
https://doaj.org/article/c560ecaa3fe24937b23b46640aec4f30
Autor:
Pengxuan Zhao, Xucheng Hou, Jingyue Yan, Shi Du, Yonger Xue, Wenqing Li, Guangya Xiang, Yizhou Dong
Publikováno v:
Bioactive Materials, Vol 5, Iss 2, Pp 358-363 (2020)
Lipid-like nanoparticles (LLNs) have been extensively explored for messenger RNA (mRNA) delivery in various biomedical applications. However, the long-term storage of these nanoparticles is still a challenge for their clinical translation. In this st
Externí odkaz:
https://doaj.org/article/28560ab836ea444eae9133a67fb4223e
Publikováno v:
Materials, Vol 6, Iss 3, Pp 795-804 (2013)
TiAlN/Al2O3 multilayers with different Ar/N2 ratios were deposited on Si substrates in different N2 partial pressure by magnetron sputtering. The crystalline and multilayer structures of the multilayers were determined by a glancing angle X-ray diffr
Externí odkaz:
https://doaj.org/article/bffac65742ef4b83a7f803d3bfce8379
Autor:
Yuebao Zhang, Jingyue Yan, Xucheng Hou, Chang Wang, Diana D. Kang, Yonger Xue, Shi Du, Binbin Deng, David W. McComb, Shan-Lu Liu, Yichen Zhong, Yizhou Dong
Publikováno v:
Nano Letters. 23:2593-2600
Autor:
Zhaoding Wang, Chuan Peng, Yi Zheng, Yunwen Zhang, Taoran Xu, Jingyue Yan, Yeqiang Zhou, Yang Liu, Huixu Xie, Chuan Wang, Hong Tan, Qiang Fu, Mingming Ding
Publikováno v:
Advanced Functional Materials.
Autor:
Yi Zheng, Yang Liu, Zhongchao Wu, Chuan Peng, Zuojie Wang, Jingyue Yan, Yue Yan, Zifen Li, Congcong Liu, Jianxin Xue, Hong Tan, Qiang Fu, Mingming Ding
Publikováno v:
Advanced Materials.
Autor:
Jin-Qing, Liu, Chengxiang, Zhang, Xinfu, Zhang, Jingyue, Yan, Chunxi, Zeng, Fatemeh, Talebian, Kimberly, Lynch, Weiyu, Zhao, Xucheng, Hou, Shi, Du, Diana D, Kang, Binbin, Deng, David W, McComb, Xue-Feng, Bai, Yizhou, Dong
Publikováno v:
J Control Release
Cytokines are important immunotherapeutics with approved drugs for the treatment of human cancers. However, systemic administration of cytokines often fails to achieve adequate concentrations to immune cells in tumors due to dose-limiting toxicity. T